Komori
Daito Pharmaceutical (4577) · TargetMitigated

Reducing the interest-bearing debt ratio and strengthening equity capital

First written in FY2016. 17 of 39 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-10-14.

39entries
11years
3from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017-Q3 – FY2019WorsenedFY2023-Q1 – FY20252016: 22017: 420172018: 420182019: 420192020: 420202021: 320212022: 420222023: 420232024: 320242025: 220252026: 52026
Same theme, other companies
Improving Financial Strength Through Debt Reduction and Net Asset GrowthA theme 37 companies write about · 0 as a headwind · 43 as a tailwind

Daito Pharmaceutical moved to the "Worse" side of this theme in 2023, 1 year after the typical company in this theme (2022).

The whole theme swung hardest in 2017: 2 of 16 companies on the "Worse" side.

4 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 37 companies compared. The sentences above are computed from all 37.
Full recordFilings, disclosures and news, newest first
  1. 2026-10-14MitigatedEarnings

    「これらの結果、自己資本比率は前連結会計年度より1.0ポイント上昇し、73.2%となっております。」

    自己資本比率が前期末の72.2%から73.2%へ上昇し、財務体質の改善方向を継続している。
  2. FY2026MitigatedAnnual report

    「Liabilities decreased by ¥5,584 million from the end of the previous consolidated fiscal year to ¥20,352 million. As a result, the equity ratio increased by 5.5 percentage points from the previous consolidated fiscal year to 72.2%, while return on equity (ROE) increased by 2.3 percentage points to 6.0%.」

    Liabilities decreased, while the equity ratio rose from 66.7% to 72.2% and ROE increased from 3.7% to 6.0%. The indicators related to improving the financial position and strengthening equity improved.
  3. FY2026-H1MitigatedAnnual report

    「Liabilities decreased by ¥1,298 million from the end of the previous consolidated fiscal year to ¥24,638 million. This was mainly due to a ¥1,449 million decrease in long-term borrowings. As a result, the equity ratio increased by 1.2 percentage points from the previous consolidated fiscal year to 67.9%.」

    Liabilities and long-term borrowings decreased, while the equity ratio rose from 66.7% at the end of the previous period to 67.9%. The indicators related to improving the financial position improved during the current interim period.
  4. FY2025WorsenedAnnual report

    「As a result, the equity ratio decreased by 0.3 percentage points from the previous consolidated fiscal year to 66.7%, while return on equity (ROE) decreased by 2.7 percentage points to 3.7%.」

    Liabilities increased by ¥493 million, while the equity ratio declined from 67.0% to 66.7% and ROE fell from 6.4% to 3.7%. The indicators related to improving the financial position and strengthening equity deteriorated.
  5. FY2025-H1WorsenedAnnual report

    「Liabilities increased by ¥2,169 million from the end of the previous consolidated fiscal year to ¥27,612 million. This was mainly due to increases of ¥3,350 million in long-term borrowings and ¥1,199 million in the current portion of long-term borrowings, offset by a decrease of ¥3,356 million in other current liabilities, among other factors. As a result, the equity ratio decreased by 1.7 percentage points from the previous consolidated fiscal year to 65.3%.」

    Long-term borrowings and the current portion of long-term borrowings increased, while the equity ratio also declined from 67.0% to 65.3%. The indicators related to improving the financial position and strengthening equity deteriorated.
  6. FY2024WorsenedAnnual report

    「As a result, the equity ratio decreased by 4.8 percentage points from the previous consolidated fiscal year to 67.0%, while return on equity (ROE) decreased by 0.9 percentage points to 6.4%.」

    The equity ratio declined from 71.8% to 67.0%, and ROE fell from 7.3% to 6.4%. The indicators related to improving the financial position and strengthening equity deteriorated.
  7. FY2024-Q3WorsenedAnnual report

    「Liabilities increased by ¥5,725 million from the end of the previous consolidated fiscal year to ¥25,306 million. This was mainly due to a ¥358 million decrease in electronically recorded obligations, offset by increases of ¥2,119 million in notes and accounts payable, ¥1,825 million in long-term borrowings, and ¥680 million in the current portion of long-term borrowings, among other factors. As a result, the equity ratio decreased by 4.8 percentage points from the previous consolidated fiscal year to 67.0%.」

    Liabilities increased by ¥5,725 million from the end of the previous consolidated fiscal year, and both long-term borrowings and the current portion of long-term borrowings increased. The equity ratio declined from 71.8% to 67.0%.
  8. FY2024-Q2WorsenedAnnual report

    「Liabilities increased by ¥3,287 million from the end of the previous consolidated fiscal year to ¥22,868 million. This was mainly due to a decrease of ¥2,328 million in other current liabilities, offset by increases of ¥2,064 million in notes and accounts payable, ¥2,350 million in long-term borrowings, and ¥700 million in the current portion of long-term borrowings, among other factors. As a result, the equity ratio decreased by 2.6 percentage points from the previous consolidated fiscal year to 69.2%.」

    Liabilities increased by ¥3,287 million from the end of the previous consolidated fiscal year, and both long-term borrowings and the current portion of long-term borrowings increased. The equity ratio declined from 71.8% to 69.2%, indicating deterioration in the indicators related to improving the financial position.
  9. FY2024-Q1WorsenedAnnual report

    「Liabilities increased by ¥602 million from the end of the previous consolidated fiscal year to ¥20,183 million. This was mainly due to decreases of ¥535 million in other current liabilities and ¥324 million in long-term borrowings, offset by increases of ¥1,085 million in notes and accounts payable and ¥453 million in electronically recorded obligations, among other factors. As a result, the equity ratio decreased by 0.4 percentage points from the previous consolidated fiscal year to 71.4%.」

    Total liabilities increased by ¥602 million, and the equity ratio also declined from 71.8% to 71.4%. Although long-term borrowings decreased, the key indicators related to improving the financial position deteriorated.
  10. FY2023WorsenedAnnual report

    「Liabilities increased by ¥2,315 million from the end of the previous consolidated fiscal year to ¥19,580 million. This was mainly due to a decrease of ¥842 million in income taxes payable, among other factors, offset by increases of ¥1,812 million in accounts payable and ¥1,120 million in long-term borrowings, among other factors. As a result, the equity ratio decreased by 1.0 percentage point from the previous consolidated fiscal year to 71.8%, while return on equity (ROE) decreased by 3.2 percentage points to 7.3%.」

    Liabilities and long-term borrowings increased, while the equity ratio declined from 72.8% to 71.8% and ROE fell from 10.5% to 7.3%. The indicators related to the theme of improving the financial position deteriorated.
  11. FY2023-Q3WorsenedAnnual report

    「Liabilities increased by ¥1,484 million from the end of the previous consolidated fiscal year to ¥18,750 million. This was mainly due to decreases of ¥1,237 million in income taxes payable and ¥1,072 million in other current liabilities, offset by increases of ¥1,237 million in notes and accounts payable, ¥490 million in electronically recorded obligations, and ¥1,456 million in long-term borrowings, among other factors. As a result, the equity ratio decreased by 0.6 percentage points from the previous consolidated fiscal year to 72.2%.」

    Liabilities increased by ¥1,484 million from the end of the previous consolidated fiscal year, and long-term borrowings also increased by ¥1,456 million, while the equity ratio declined from 72.8% to 72.2%.
  12. FY2023-Q2WorsenedAnnual report

    「Liabilities increased by ¥4,328 million from the end of the previous consolidated fiscal year to ¥21,593 million. This was mainly due to a ¥447 million decrease in income taxes payable, offset by increases of ¥1,901 million in other current liabilities and ¥1,801 million in long-term borrowings, among other factors. As a result, the equity ratio decreased by 3.7 percentage points from the previous consolidated fiscal year to 69.1%.」

    Liabilities increased by ¥4,328 million from the end of the previous consolidated fiscal year, and long-term borrowings also increased by ¥1,801 million. The equity ratio declined from 72.8% to 69.1%, indicating further deterioration in the indicators related to improving the financial position.
  13. FY2023-Q1WorsenedAnnual report

    「Liabilities increased by ¥3,441 million from the end of the previous consolidated fiscal year to ¥20,707 million. This was mainly due to a ¥1,071 million decrease in income taxes payable, offset by increases of ¥1,036 million in notes and accounts payable, ¥474 million in current portion of long-term borrowings, ¥481 million in electronically recorded obligations, and ¥2,175 million in long-term borrowings, among other factors. As a result, the equity ratio decreased by 3.2 percentage points from the previous consolidated fiscal year to 69.6%.」

    Liabilities increased by ¥3,441 million from the end of the previous consolidated fiscal year, and long-term borrowings also increased by ¥2,175 million, while the equity ratio declined from 72.8% to 69.6%.
  14. FY2022Equity ratio rises alongside changes in debt indicatorsAnnual report

    「As a result, the equity ratio increased by 0.7 percentage points from the previous consolidated fiscal year to 72.8%, while return on equity (ROE) decreased by 0.4 percentage points to 10.5%.」

    The equity ratio rose from 72.1% to 72.8%, while ROE declined from 10.9% to 10.5% and the cash flow to interest-bearing debt ratio increased from 0.7 years to 0.8 years.
  15. FY2022-Q3AdvancedAnnual report

    「As a result, the equity ratio increased by 1.2 percentage points from the previous consolidated fiscal year to 73.3%.」

    The equity ratio rose 1.2 percentage points from 72.1% at the end of the previous consolidated fiscal year to 73.3%. It also increased from the 72.6% reported immediately prior in FY2022-Q2.
  16. FY2022-Q2Equity ratio down from the previous quarterAnnual report

    「As a result, the equity ratio increased by 0.5 percentage points from the previous consolidated fiscal year to 72.6%.」

    The equity ratio rose from 72.1% at the end of the previous consolidated fiscal year to 72.6%, but declined from 73.3% reported immediately prior in FY2022-Q1.
  17. FY2022-Q1AdvancedAnnual report

    「As a result, the equity ratio increased by 1.2 percentage points from the previous consolidated fiscal year to 73.3%.」

    The equity ratio rose 1.2 percentage points from 72.1% at the end of the previous consolidated fiscal year to 73.3%.
  18. FY2021-Q3Equity ratio down from the previous quarterAnnual report

    「As a result, the equity ratio increased by 2.2 percentage points from the previous consolidated fiscal year to 69.5%.」

    The equity ratio rose 2.2 percentage points from 67.3% at the end of the previous consolidated fiscal year to 69.5%, but declined from 70.6% at the time of the previous quarterly report.
  19. FY2021-Q2AdvancedAnnual report

    「As a result, the equity ratio increased by 3.3 percentage points from the previous consolidated fiscal year to 70.6%.」

    The equity ratio rose 3.3 percentage points from 67.3% at the end of the previous consolidated fiscal year to 70.6%.
  20. FY2021-Q1AdvancedAnnual report

    「Liabilities decreased by ¥2,172.315 million from the end of the previous consolidated fiscal year to ¥15,209.057 million. As a result, the equity ratio increased by 4.2 percentage points from the previous consolidated fiscal year to 71.5%.」

    Liabilities decreased by ¥2,172.315 million from the end of the previous consolidated fiscal year, and the equity ratio rose from 67.3% to 71.5%. This indicates specific progress in the indicators related to improving the financial position.
  21. FY2020AdvancedAnnual report

    「As a result, the equity ratio increased by 1.1 percentage points from the previous consolidated fiscal year to 67.3%, while return on equity (ROE) increased by 0.3 percentage points to 11.7%.」

    The equity ratio rose from 66.2% to 67.3%, while the cash flow to interest-bearing debt ratio was 0.7 years, unchanged from the previous period.
  22. FY2020-Q3RestatedAnnual report

    「As a result, the equity ratio was 66.2%, unchanged from the end of the previous consolidated fiscal year.」

    The equity ratio was 66.2%, unchanged from the end of the previous consolidated fiscal year, indicating no change in the indicators related to improving the financial position.
  23. FY2020-Q2AdvancedAnnual report

    「As a result, the equity ratio increased by 0.4 percentage points from the end of the previous consolidated fiscal year to 66.6%.」

    The equity ratio rose 0.4 percentage points from 66.2% at the end of the previous consolidated fiscal year to 66.6%.
  24. FY2020-Q1WorsenedAnnual report

    「As a result, the equity ratio decreased by 0.9 percentage points from the previous consolidated fiscal year to 65.3%.」

    The equity ratio declined from 66.2% at the end of the previous consolidated fiscal year to 65.3%, indicating a temporary deterioration in the indicator related to improving the Company's financial position.
  25. FY2019AdvancedAnnual report

    「Liabilities decreased by ¥3,003 million from the end of the previous consolidated fiscal year to ¥15,399 million. This was mainly due to decreases of ¥1,400 million in short-term borrowings, ¥792 million in accounts payable and ¥925 million in long-term borrowings, among others, despite an increase of ¥465 million in notes and accounts payable, among others. As a result, the equity ratio increased by 6.4 percentage points from the previous consolidated fiscal year to 66.2%, while return on equity (ROE) increased by 0.6 percentage points to 11.4%.」

    Total liabilities, short-term borrowings and long-term borrowings decreased, while the equity ratio rose from 59.8% to 66.2% and ROE rose to 11.4%. The Company reported specific progress in indicators related to improving its financial position.
  26. FY2019-Q3AdvancedAnnual report

    「As a result, the equity ratio increased by 1.3 percentage points from the end of the previous consolidated fiscal year to 61.1%.」

    The equity ratio rose 1.3 percentage points from the end of the previous consolidated fiscal year to 61.1%.
  27. FY2019-Q2AdvancedAnnual report

    「As a result, the equity ratio increased by 1.0 percentage point from the end of the previous consolidated fiscal year to 60.8%.」

    The equity ratio rose 1.0 percentage point from 59.8% at the end of the previous consolidated fiscal year to 60.8%.
  28. FY2019-Q1AdvancedAnnual report

    「As a result, the equity ratio increased by 0.6 percentage points from the previous consolidated fiscal year to 60.4%.」

    The equity ratio rose 0.6 percentage points from the end of the previous consolidated fiscal year to 60.4%. However, short-term borrowings increased, so the Company does not characterize this as an overall improvement in financial indicators.
  29. FY2018AdvancedAnnual report

    「As a result, the equity ratio increased by 4.0 percentage points from the previous consolidated fiscal year to 59.5%.」

    The equity ratio rose from 55.5% to 59.5%, while interest-bearing debt decreased from ¥8,532 million to ¥7,402 million based on the period-end balance.
  30. FY2018-Q3AdvancedAnnual report

    「As a result, the equity ratio increased by 2.7 percentage points from the previous consolidated fiscal year to 58.2%.」

    The equity ratio rose 2.7 percentage points from 55.5% at the end of the previous consolidated fiscal year to 58.2%.
  31. FY2018-Q2AdvancedAnnual report

    「As a result, the equity ratio increased by 0.9 percentage points from the previous consolidated fiscal year to 56.4%.」

    The equity ratio rose 0.9 percentage points from 55.5% at the end of the previous consolidated fiscal year to 56.4%.
  32. FY2018-Q1AdvancedAnnual report

    「As a result, the equity ratio increased by 0.1 percentage point from the previous consolidated fiscal year to 55.6%.」

    The equity ratio rose 0.1 percentage point from 55.5% at the end of the previous consolidated fiscal year to 55.6%. The Company reported a modest improvement in an indicator related to its policy of improving its financial position.
  33. FY2017AdvancedAnnual report

    「As a result, the equity ratio increased by 2.1 percentage points from the previous consolidated fiscal year to 55.5%.」

    The equity ratio rose from 53.4% to 55.5%. Interest-bearing debt also decreased based on the period-end balance, and the cash flow-to-interest-bearing debt ratio was 1.7 years.
  34. FY2017-Q3AdvancedAnnual report

    「As a result, the equity ratio increased by 1.0 percentage point from the previous consolidated fiscal year to 54.4%.」

    The equity ratio rose 1.0 percentage point from the end of the previous consolidated fiscal year to 54.4%. The indicator continued to improve from the previous quarterly report in line with the policy of improving the Company's financial position.
  35. FY2017-Q2RestatedAnnual report

    「As a result, the equity ratio increased by 0.4 percentage points from the previous consolidated fiscal year to 53.8%.」

    The equity ratio rose 0.4 percentage points from the end of the previous consolidated fiscal year. There was no new change in the policy for improving the Company's financial position.
  36. FY2017-Q1AdvancedAnnual report

    「Liabilities decreased by ¥501 million from the end of the previous consolidated fiscal year to ¥19,279 million. As a result, the equity ratio increased by 0.9 percentage points from the end of the previous consolidated fiscal year to 54.3%.」

    The equity ratio rose 0.9 percentage points from the end of the previous fiscal year to 54.3%. As an increase in short-term borrowings was also reported, this is recorded as progress in one financial-base indicator rather than a definitive achievement in reducing the overall interest-bearing debt ratio.
  37. FY2016First statedAnnual report

    「Going forward, the Group plans to actively diversify its funding sources, improve its financial position by reducing its interest-bearing debt ratio, and strengthen its equity capital.」

    The Company recognizes its reliance on borrowings to fund capital expenditures and has set out plans to diversify its funding sources and improve its financial position.
Moved together

"Risks Related to Interest-Bearing Debt, Interest Rates and Financial Covenants" moved the same way as this thread, in the same document, in 18 of its 39 moves.

181212121110★123456
  1. ★This thread
  2. 1Risks Related to Interest-Bearing Debt, Interest Rates and Financial Covenants18×
  3. 2Sales Growth of Generic APIs and In-House-Developed Formulations12×
  4. 3Expansion and Rationalization of Production and R&D Facilities12×
  5. 4Sales of New Health Food Products and Related Items12×
  6. 5Customer Credit Risk11×
  7. 6Risk of fluctuations in raw-material and procurement prices10×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Daito Pharmaceutical yet. It last moved in the Earnings of 2026-10-14: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Reducing the interest-bearing debt ratio and strengthening equity capital | Daito Pharmaceutical Co.,Ltd. (4577) | Komori